Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009
Dispatch

Variation in Antimicrobial Resistance in Sporadic and Outbreak-related Salmonella enterica Serovar Typhimurium

Eva Møller NielsenComments to Author , Mia Torpdahl, Steen Ethelberg, and Anette M. Hammerum
Author affiliations: Statens Serum Institut, Copenhagen, Denmark

Main Article

Table 1

Antimicrobial resistance profile of 323 clinical Salmonella enterica serovar Typhimurium DT104 isolates, Denmark, 2003–2006*

Phenotype SGI1 genotype† Unique types, no. strains (%) All isolates, no. (%)
ACSSuT‡ SGI1§ 122 (84) 251 (78)
ACSSuTTm¶ SGI1-A 5 (3) 9 (3)
ASu SGI1-B 4 (3) 24 (7)
SSu SGI1-C 3 (2) 11 (3)
ASSuTTm SGI1-C 1 (0.7) 2 (0.6)
ASSu SGI1-B 1 (0.7) 2 (0.6)
ACST# SGI1 1 (0.7) 1 (0.3)
SSuT Not present 1 (0.7) 3 (0.9)
Sensitive
Not present
8 (6)
20 (6)
Total 146 (100) 323 (100)

*One isolate per multilocus variable number of tandem repeats analysis (MLVA) and antimicrobial resistance profile is represented in the data set of 146 strains with unique types. A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfonamides; T, tetracycline; Tm, trimethoprim.
†SGI, Salmonella genomic island. Genotype determined by the SGI1-related PCR assays described in the text (1 isolate per “unique type”); see Table 2 for selected details.
‡Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin (22 strains), amoxicillin/clavulanic acid (3 strains), gentamicin (1 strain).
§Only a small subset of 10 ACSSuT strains was tested by PCR for the presence of SGI1 genes.
¶Additional antimicrobial-drug resistances: nalidixic acid, ciprofloxacin, and gentamicin (1 strain).
#Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin.

Main Article

Page created: December 06, 2010
Page updated: December 06, 2010
Page reviewed: December 06, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external